More than 44,000 chemists and druggists across Maharashtra will go on a two-day strike on January 11 and 12 to protest the 'draconian' measure by the Food and Drug Administration, which proposed withdrawal of licences in case of any violation.
More than 44,000 chemists and druggists across Maharashtra would go on a two-day strike on January 11 and 12
Nestle refused to regret the mistake in a public statement.
Cadila Healthcare Ltd has received tentative approval from US FDA to market its antibiotic, Gatifloxacin tablets, 200 mg and 400 mg, in the US market.
Scientists have developed a new and more effective drug to help smokers quit the habit, which is known to reduce the life span of those addicted by about 10 years and is the single most important factor for heart attacks the world over.
Analysts are eyeing bigger launches that will positively impact company's fortunes.
Cadila Healthcare Ltd on Monday said it has received tentative approval from the US FDA to market Levofloxacin tablets of 250 mg, 500 mg and 750 mg in the US market.
The Maharashtra Food and Drug Administration has ordered withdrawal of Amulspray from Mumbai with immediate effect.
United States' Food and Drug Administration has granted approval to Ranbaxy Laboratories Ltd to manufacture and market 40 mg capsules of Fluoxetine, a drug used in treatment of obsessive-compulsive disorders.\n\n
The US Food and Drug Administration has asked USV to probe employees who might have been responsible for inaccurate data reporting.
Riluzole is indicated for the treatment of amyotrophic lateral sclerosis.
The worms were detected in Elferri capsules, manufactured by a Goan company. The FDA has initiated a probe.
Global generic drugs producer Sandoz has opened its third plant in India at Navi Mumbai with annual production capacity of one billion tablets and capsules.
Facing arbitration claims by Daiichi Sankyo, Ranbaxy's former Indian promoters - Malvinder Mohan Singh, his brother Shivinder Mohan Singh and family - are counting on certain clauses in the share purchase agreement (SPA) signed with the Japanese company on June 11, 2008, to claim immunity from damages.
The presence of ants was detected at Alibag in Maharashtra and subsequently a complaint was lodged with the Food and Drug Administration authorities.
Dinesh Thakur is famous for exposing Ranbaxy safety problems
Kapiva's plans to introduce allopathy-like doses of ayurvedic remedies for the millennial consumer finds traction.
Ranbaxy Laboratories on Friday said it has received tentative approval from US Food and Drug Administration to manufacture and market Ofloxacin, the generic version of Ortho Mcneil Pharmaceutical Inc's Floxin.
Ranbaxy drugs sold in the United States will be gradually rebranded as Sun Pharma treatments
Goa on Sunday joined several other states in banning the sale of Nestle's instant noodle brand 'Maggi' which is at the centre of a raging nationwide row over food safety concerns.
Financials were the top losers while oil shares also declined amid weak crude oil prices.
Experts question Nestle's silence over Maggi controversy.
The 50-share NSE Nifty stayed in the positive zone and retook the 9,900-mark to hit a high of 9,905.05 as buying paced up towards the fag end. It settled higher by 72.45 points, or 0.74 per cent, at 9,899.60.
We are surrounded by food that is contaminated, adulterated and does not meet Indian safety and packaging standards, says Abheet Singh Sethi/IndiaSpend.com.
Punishing brand ambassadors shows that the government is only interested in going after the low hanging fruit, says Tanmaya Nanda.
Lupin was the top gainer after the USFDA cleared its Goa facility
The broader markets ended negatively with mid-caps and small-caps shedding 0.5 per cent on the BSE.
In the Sensex pack, ICICI Bank emerged as the top gainer by rising 0.97 per cent, while Tata Steel advanced 0.92 per cent.
The procedure, however, would cost around Rs 75,000-100,000 more than conventional angioplasty.
Daiichi alleged that Singh brothers had concealed and misrepresented critical information concerning US Food and Drug Administration and Department of Justice investigations into Ranbaxy
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances